Sino Biopharmaceutical Ltd 1177.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 05/17/24 CTT
3.09quote price arrow down-0.03 (-0.96%)
Volume
41,359,581
52 week range
2.29 - 4.16
Loading...
  • Open3.11
  • Day High3.16
  • Day Low3.07
  • Prev Close3.12
  • 52 Week High4.16
  • 52 Week High Date05/16/23
  • 52 Week Low2.29
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap7,301.34M
  • Shares Out18,347.12M
  • 10 Day Average Volume52.17M
  • Dividend0.05
  • Dividend Yield1.62%
  • Beta0.68
  • YTD % Change-10.95

KEY STATS

  • Open3.11
  • Day High3.16
  • Day Low3.07
  • Prev Close3.12
  • 52 Week High4.16
  • 52 Week High Date05/16/23
  • 52 Week Low2.29
  • 52 Week Low Date04/19/24
  • Market Cap7,301.34M
  • Shares Out18,347.12M
  • 10 Day Average Volume52.17M
  • Dividend0.05
  • Dividend Yield1.62%
  • Beta0.68
  • YTD % Change-10.95

RATIOS/PROFITABILITY

  • EPS (TTM)0.14
  • P/E (TTM)22.39
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/11/2024
  • Div Amount0.03
  • Split Date-
  • Split Factor-

Latest On Sino Biopharmaceutical Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long term and short term investments. The Other segment is...
Y Y Tse
Executive Chairwoman of the Board
Cheung Ling Cheng
Executive Vice Chairwoman of the Board
Ping Tse
Senior Executive Vice Chairman of the Board
S. Y. Tse
Chief Executive Officer, Executive Director
Chunling Li
Chief Financial Officer
Song Jin
Vice President - Public Affairs and ESG
Address
Unit 09, 41F, Office Tower
Convention Plaza, No. 1 Harbour Road
Wanchai
Hong Kong